Navigation Links
Autoimmune Response in Multiple Sclerosis

In multiple sclerosis (MS), the myelin that surrounds the axons of nerve cells is attacked by the bodys own T cells, resulting in slowed and disrupted nerve impulses and, ultimately, axon loss .

Myelin basic protein (MBP) is a major component of the myelin sheath and when used as an antigen will induce experimental autoimmune encephalitis (EAE) in mice, which is used as an animal model of human MS.

Interestingly, myelin-specific T cells are found in both healthy individuals as well as patients with MS, thus researchers have been working to determine what specific characteristic of these destructive T cells is dominant in driving the development of EAE/MS.

In a study appearing online on July 12 in advance of publication in the August print issue of the Journal of Clinical Investigation, Eli Sercarz and colleagues from the Torrey Pines Institute for Molecular Studies immunized mice with an epitope of MBP known as Ac19, which resulted in a single episode of EAE in these animals, followed by recovery and resistance to any reinduction of disease.

The authors then went on to characterize the Ac19specific T cells present during the induction, onset, and recovery from disease. They identified two distinct subsets of T cells, or clonotypes, soon after immunization and prior to disease onset: BV8S2/BJ2S7 and BV16/BJ2S5.

The BV8S2/BJ2S7 clonotype was found in far greater excess, disappeared with disease recovery, and was found to transfer disease to other healthy mice.

The second clonotype, BV16/BJ2S5, persisted following recovery, consistent with the hypothesis that the other, BV8S2/BJ2S7 T cell clonotype, is the driver of disease and necessary for EAE/MS persistence. The identification of this T cell subset suggests that these cells may be critical targets valuable to the design of therapies for autoimmune diseases such as MS.

AUTHOR CONTACT: Eli E. Sercarz Torrey Pines Institute for
'"/>




Page: 1 2

Related medicine news :

1. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
2. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
3. Autoimmune disorder caused due to mutation in cryopyrin protein
4. Gold Therapy- A Potential Treatment For Autoimmune Diseases
5. Autoimmune Diseases – Newer Preventive Measure
6. Autoimmune disorders studied in detail by U-M researchers.
7. Understanding Autoimmune Disease
8. A Single Biological Mechanism Behind Several Autoimmune Disorders
9. Researchers Discover New Molecular Path to Fight Autoimmune Diseases
10. Autoimmune Diseases can Be Prevented by Green Tea
11. New Therapeutic Approach for Autoimmune and Inflammatory Diseases
Post Your Comments:
(Date:10/13/2008)...ropean study suggests that the combination of low ...ure from the sun is associated with certain forms ...n (AMD), according to a report in the October issu.../Archives journals. , "The retina is vulnerable...ite as background information in the article. "Whi...
(Date:10/13/2008)...W YORK, Oct. 13 /PRNewswire-USNewswire/ -- As the ...General, Ban Ki-Moon, on fistula is,scheduled to b...o End,Fistula announced a fourfold increase in the...nnual report, the campaign now works to prevent an...ia and the Arab States. When it,was launched in 20...
(Date:10/13/2008)...tional Latino AIDS Awareness Day Encourages Latino.../ --, WHAT, -- Latinos make up almost half of al...ngeles County compared to 19 percent nationally., ...s and encouraging HIV,counseling and testing to co...erved on October 15., -- October 14, Our Communit...
(Date:10/13/2008)...ch alcohol has a greater effect on women, study fo... -- The more alcohol you drink, the more your brai...home message is that, if you drink a lot, you,re g...associate professor of neuroscience and experiment...e Center College of Medicine. "This is something w...
Breaking Medicine News(10 mins):Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 3Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Excess Drinking Shrinks the Brain 2
...that she chants as she decides what to do with her...g is used by many Buddhists celebrities including ...py. Love reportedly wrote on her website: "I chan...night and really thought about where the money sho...
...h Wine Fair (Fenavin) here, India has said it woul...ions in production if a strong element of "price s...tivity does not necessarily mean selling the cheap...of the Delhi Wine Club, told delegates at the thre...
... away for talented actress Kangana Ranaut but that...es she wants in Mr.Right! "I'm going to get marr...find Mr. Right," Kangana told IANS. "He should b...d real... not a mannequin. He has to be a white-co...
...ave found a treatment, which could block the actio...ncer. The enzyme PTP1B appears to fuel tumor grow...in treating the disease. About 40 percent of human...shown to have excessively high levels of this enzy...
Other Medicine News:Health News:India is Uncorking Its Wine Market: Expert 2Health News:Gentle, Real, Well-mannered - Kangana's Mr. Right 2
(Date:10/8/2008)...l Reduce Animal Use in Cosmetics and Chemicals Tes...ek Corp. today announced,that results of a recentl...h-up" validation study on MatTek,s EpiDerm in vitr...emonstrated the required sensitivity and,specifici...native to animal,testing for determining human ski...
(Date:10/8/2008)...b Program to be Discontinued and Headcount to be R...ts Portfolio Review; Zanolimumab Program to be Di...of Employees, COPEN...A/S (OMX: GEN),announced today that it is disconti...n addition, as a result of a portfolio review and,...
(Date:10/8/2008)... Confirm Potency of Poly-ICR as Vaccine Adjuvant, ...a Biopharmaceuticals,Corporation (TSX: NVN) today ...sing its proprietary Toll-like Receptor 3 agonist,...ccine Congress 2008 in Lyon, France.,Study results...vant,targeting the Toll-like Receptor 3 (TLR3) pat...
(Date:10/7/2008).... 7 /- Prometheus Laboratories Inc., ...d findings from its,development of PROMETHEUS(R) I...rritable bowel syndrome (IBS). The findings sugges...icular biomarkers in blood samples,between IBS and...markers,combined with a proprietary algorithm, le...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Blood Donations in U S Testing Positive for Chagas Disease 1389 1Blood Donations in U S Testing Positive for Chagas Disease 1389 2Blood Donations in U S Testing Positive for Chagas Disease 1389 3Blood Donations in U S Testing Positive for Chagas Disease 1389 4American Diabetes Association Steps Up to Fight Diabetes 4208 1American Diabetes Association Steps Up to Fight Diabetes 4208 2American Diabetes Association Steps Up to Fight Diabetes 4208 3Fenwal Signs Development Distribution and Licensing Agreement With Data Innovations Inc 4206 1Fenwal Signs Development Distribution and Licensing Agreement With Data Innovations Inc 4206 2Fall Time Change Could Be Boon for Sleep 4204 1Fall Time Change Could Be Boon for Sleep 4204 2
...05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc. to...inical study of novel monoclonal antibodies agains...rate that NTB-A is a,potential new target for immu...a and lymphomas. The study, entitled "The lymphoid...ntibody target for,leukemia and lymphoma therapeut...
...S WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX: ...g,oral spray formulations for a broad range of mar...nical studies comparing zolpidem,oral spray with z...etic (PK), pharmacodynamic (PD) and safety objecti...bien(R), a leading,drug for the treatment of insom...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: